Terms: = Breast cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037
9661 results:
1. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
He ZX; Li J; Wang QF; Cheng Q; Ni SJ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
[No Abstract] [Full Text] [Related]
2. [Feasibility analysis of the application of programmed process endoscopic lateral neck dissection via chest-breast approach in papillary thyroid carcinoma surgery].
Xu N; Li ZY; Luo XP; Gao HY; Huang JF; Wang YY; Liu XJ; Xu B
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1831-1836. PubMed ID: 38782751
[No Abstract] [Full Text] [Related]
3. The diagnostic value of multimodal imaging based on MR combined with ultrasound in benign and malignant breast diseases.
Bai D; Zhou N; Liu X; Liang Y; Lu X; Wang J; Liang L; Wang Z
Clin Exp Med; 2024 May; 24(1):110. PubMed ID: 38780895
[TBL] [Abstract] [Full Text] [Related]
4. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer.
Cui Z; Li Y; Lin Y; Zheng C; Luo L; Hu D; Chen Y; Xiao Z; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1328679. PubMed ID: 38779451
[TBL] [Abstract] [Full Text] [Related]
5. Antibiotic Resistance Profile of
Kengne MF; Mbaveng AT; Kuete V
Biomed Res Int; 2024; 2024():5859068. PubMed ID: 38778831
[TBL] [Abstract] [Full Text] [Related]
6. Validation and responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in breast cancer patients.
Kraehenbuehl L; Kang D; Bang AS; Ketosugbo KF; Hay J; Patil S; Goldfarb S; Cho J; Lacouture ME
Support Care Cancer; 2024 May; 32(6):369. PubMed ID: 38773008
[TBL] [Abstract] [Full Text] [Related]
7. Performance of Diffusion-weighted Imaging-based Noncontrast MRI Protocols for Diagnosis of breast cancer: A Systematic Review and Meta-Analysis.
Pötsch N; Sodano C; Baltzer PAT
Radiology; 2024 May; 311(2):e232508. PubMed ID: 38771179
[TBL] [Abstract] [Full Text] [Related]
8. A meta-analysis of MRI radiomics-based diagnosis for BI-RADS 4 breast lesions.
Lin J; Zheng H; Jia Q; Shi J; Wang S; Wang J; Ge M
J Cancer Res Clin Oncol; 2024 May; 150(5):254. PubMed ID: 38748373
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.
Man X; Huang J; Sun S; Zhou D; Zhang B; Fang S; Zheng F; Li C; Wang X; Huang W; Wang L; He Q; Fu H; Zhang Y; Liu C; Dong L; Zhao X; Xu L; Sun X; Fan B; Song L; Zhou Z; Yu J; Li H
Clin Transl Med; 2024 May; 14(5):e1687. PubMed ID: 38738791
[TBL] [Abstract] [Full Text] [Related]
10. Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours.
Zago Baltazar R; Claerhout S; Vander Borght S; Spans L; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Renard M; van den Hout MF; Vernemmen A; Libbrecht L; De Roo AK; Mazzeo F; van Marcke C; Deraedt K; Bourgain C; Vanden Bempt I
J Pathol Clin Res; 2024 May; 10(3):e12376. PubMed ID: 38738521
[TBL] [Abstract] [Full Text] [Related]
11. Advanced-stage breast cancer diagnosis and its determinants in Ethiopia: a systematic review and meta-analysis.
Zewdie A; Kassie TD; Anagaw TF; Mazengia EM; Gelaw SS; Fenta ET; Eshetu HB; Kebede N; Bogale EK
BMC Womens Health; 2024 May; 24(1):284. PubMed ID: 38734607
[TBL] [Abstract] [Full Text] [Related]
12. Shared decision-making for supporting women's decisions about breast cancer screening.
Riganti P; Ruiz Yanzi MV; Escobar Liquitay CM; Sgarbossa NJ; Alarcon-Ruiz CA; Kopitowski KS; Franco JV
Cochrane Database Syst Rev; 2024 May; 5(5):CD013822. PubMed ID: 38726892
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment.
Bardakci M; Karakas H; Bayram D; Avci N; Kitapli S; Ozen M; Aslan F; Koseoglu C; Kadioglu A; Onur ID; Sakalar T; Buyuksimsek M; Alkan A; Ergun Y; Kaya AO; Bilgin B; Yalcin B
Sci Rep; 2024 May; 14(1):10632. PubMed ID: 38724585
[TBL] [Abstract] [Full Text] [Related]
14. Structured illumination microscopy for cancer identification in diagnostic breast biopsies.
Behr M; Alizadeh L; Buckner-Baiamonte L; Roberts B; Sholl AB; Brown JQ
PLoS One; 2024; 19(5):e0302600. PubMed ID: 38722960
[TBL] [Abstract] [Full Text] [Related]
15. Declination of Treatment, Racial and Ethnic Disparity, and Overall Survival in US Patients With breast cancer.
Freeman JQ; Li JL; Fisher SG; Yao KA; David SP; Huo D
JAMA Netw Open; 2024 May; 7(5):e249449. PubMed ID: 38722630
[TBL] [Abstract] [Full Text] [Related]
16. Outcome and Factors Related to Isolated Liver Metastasis due to breast cancer.
Sen E; Canbak T; Bostanci O; Battal M
J Coll Physicians Surg Pak; 2024 May; 34(5):604-609. PubMed ID: 38720224
[TBL] [Abstract] [Full Text] [Related]
17. Preliminary efficacy and safety of YSCH-01 in patients with advanced solid tumors: an investigator-initiated trial.
He Y; Huang X; Li X; Liu H; Liu M; Tao J; Shan Y; Raza HK; Liu Y; Zhong W; Cao XP; Yang YY; Li R; Fang XL; Zhang KJ; Zhang R; Liu F
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38719544
[TBL] [Abstract] [Full Text] [Related]
18. Effect of young age (below 40 years) on oncologic outcomes in Lebanese patients with breast cancer: a matched cohort study.
Sbaity E; Tamim H; El-Hajj Fuleihan G; Abbas J; Zahwe M; El Sayed R; Shamseddine A
BMC Cancer; 2024 May; 24(1):560. PubMed ID: 38704543
[TBL] [Abstract] [Full Text] [Related]
19. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T; Cottone F; Dunton K; André F; Krop I; Park YH; De Laurentiis M; Miyoshi Y; Armstrong A; Borrego MR; Yerushalmi R; Duhoux FP; Takano T; Lu W; Egorov A; Kim SB
Lancet Oncol; 2024 May; 25(5):614-625. PubMed ID: 38697155
[TBL] [Abstract] [Full Text] [Related]
20. Addition of Contrast-enhanced Mammography to Tomosynthesis for breast cancer Detection in Women with a Personal History of breast cancer: Prospective TOCEM Trial Interim Analysis.
Berg WA; Berg JM; Bandos AI; Vargo A; Chough DM; Lu AH; Ganott MA; Kelly AE; Nair BE; Hartman JY; Waheed U; Hakim CM; Harnist KS; Reginella RF; Shinde DD; Carlin BA; Cohen CS; Wallace LP; Sumkin JH; Zuley ML
Radiology; 2024 Apr; 311(1):e231991. PubMed ID: 38687218
[TBL] [Abstract] [Full Text] [Related]
[Next]
